Publicacións nas que colabora con Carmen María Evora García (18)

2022

  1. Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice

    Journal of Nanobiotechnology, Vol. 20, Núm. 1

  2. New local ganirelix sustained release therapy for uterine leiomyoma. Evaluation in a preclinical organ model

    Biomedicine and Pharmacotherapy, Vol. 156

  3. Screening strategies for surface modification of lipid-polymer hybrid nanoparticles

    International Journal of Pharmaceutics, Vol. 624

2021

  1. Adaptación de la asignatura de Biofarmacia y Farmacocinética a la no presencialidad en el contexto del covid-19: Estrategias empleadas e impacto en los resultados académicos

    La transformación digital de la universidad: XI CIDU Congreso Iberoamericano de Docencia Universitaria

  2. Apósitos de alginato-quitosano elaborados “capa a capa”

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 208-210

  3. Tailor-made oligonucleotide-loaded lipid-polymer nanosystems designed for bone gene therapy

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 598-607

  4. The bone regeneration capacity of bmp-2 + mmp-10 loaded scaffolds depends on the tissue status

    Pharmaceutics, Vol. 13, Núm. 7

2019

  1. ScCO2-foamed silk fibroin aerogel/poly(ϵ-caprolactone) scaffolds containing dexamethasone for bone regeneration

    Journal of CO2 Utilization, Vol. 31, pp. 51-64

2018

  1. Mobility of Water and Polymer Species and Rheological Properties of Supramolecular Polypseudorotaxane Gels Suitable for Bone Regeneration

    Bioconjugate Chemistry, Vol. 29, Núm. 2, pp. 503-516

2017

  1. Biodegradable PCL/fibroin/hydroxyapatite porous scaffolds prepared by supercritical foaming for bone regeneration

    International Journal of Pharmaceutics, Vol. 527, Núm. 1-2, pp. 115-125

  2. Biodistribution of radiolabeled polyglutamic acid and PEG-polyglutamic acid nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 112, pp. 155-163

  3. Structure-Performance Relationships of Temperature-Responsive PLGA-PEG-PLGA Gels for Sustained Release of Bone Morphogenetic Protein-2

    Journal of Pharmaceutical Sciences, Vol. 106, Núm. 11, pp. 3353-3362

2015

  1. Bone critical defect repair with poloxamine-cyclodextrin supramolecular gels

    International Journal of Pharmaceutics, Vol. 495, Núm. 1, pp. 463-473

2014

  1. Bone regeneration induced by an in situ gel-forming poloxamine, bone morphogenetic protein-2 system

    Journal of Biomedical Nanotechnology, Vol. 10, Núm. 6, pp. 959-969

2013

  1. Development of PLGA-mannosamine nanoparticles as oral protein carriers

    Biomacromolecules, Vol. 14, Núm. 11, pp. 4046-4052

2005

  1. PLA-PEG particles as nasal protein carriers: The influence of the particle size

    International Journal of Pharmaceutics, Vol. 292, Núm. 1-2, pp. 43-52

2004

  1. PEG-PLA nanoparticles as carriers for nasal vaccine delivery

    Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

2000

  1. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration

    Colloids and Surfaces B: Biointerfaces, Vol. 18, Núm. 3-4, pp. 315